Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomicsStephan M. Tirier, Karsten Rippe, Jan‐Philipp Mallm et al.|Nature Communications|2021Cited by 141
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysisAlexandra M. Poos, Niels Weinhold, Lukas John et al.|Blood|2023Cited by 62
Comprehensive Comparison of Early Relapse and End-Stage Relapsed Refractory Multiple MyelomaAlexandra M. Poos, Niels Weinhold, Nicola Giesen et al.|Blood|2020Cited by 9
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myelomaLukas John, Nicola Giesen, Kaya Miah et al.|Frontiers in Oncology|2023Cited by 5
OA-23 Resolving therapy resistance mechanisms in multiple myeloma by multi-omics subclone analysisAlexandra M. Poos, Niels Weinhold, Nina Prokoph et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 2